If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
143.00    0.00 (0.00%)
Bid:
140.00
Ask:
143.00
Spread: 3.00 (2.143%)
Market Cap: £274.10m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Premium Cancellation

10 Jun 2026 12:41

RNS Number : 7986H
Franchise Brands PLC
10 June 2026
Β 

10 June 2026

FRANCHISE BRANDS PLC

("Franchise Brands", the "Group" or the "Company")

Β 

Share Premium Cancellation

Franchise Brands plc (AIM: FRAN), a platform of international B2B franchise brands focused on essential services through a mobile workforce, announces that the Share Premium Cancellation has now become effective.

Following the sanction by the High Court of England and Wales (the "Court") of the reduction of capital by way of cancellation of the Company's share premium account (the "Share Premium Cancellation") on 2 June 2026, the order of the Court confirming the Share Premium Cancellation and a statement of capital approved by the Court were registered by the Registrar of Companies on 4 June 2026.

Details of the Share Premium Cancellation were set out in the Notice of General Meeting and explanatory circular dated 24 March 2026, and the Share Premium Cancellation was approved by the shareholders of the Company at a general meeting of the Company on 30 April 2026. The effect of the Share Premium Cancellation is to create approximately Β£131.1m of distributable reserves in the accounts of the Company. This will provide the flexibility to enable the following, should circumstances make them appropriate: (i) further share buybacks; (ii) the future payment by the Company of dividends to its shareholders; and (iii) other corporate purposes of the Company.

The Share Premium Cancellation does not affect the rights attached to the Ordinary Shares and there is no change in the number of Ordinary Shares in issue (or their nominal value).

​

Enquiries:

Β 

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Peter Molloy, Chief Executive Officer

Neil Miller, Chief Financial Officer

Julia Choudhury, Corporate Development Director

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7710 7600

Matthew Blawat

Jason Grossman

Β 

Allenby Capital Limited (Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal / Tony Quirke (Sales & Corporate Broking)

Β 

MHP Group (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Hugo Harris

+44 (0) 7884 494112

franchisebrands@mhpgroup.com

Β 

About Franchise Brands plc

Franchise Brands (FTSE AIM UK 50) is a platform of international B2B franchise brands focused on essential services through a mobile workforce. We have clarity of purpose which is acquire, develop and scale proven franchise businesses. Our focus is to help our franchisees grow their businesses, so that "as they grow, we grow".

Our franchise partners benefit from our One Franchise Brands platform which includes shared, bespoke technology systems, a strategic growth maximisation methodology and management franchising expertise.

We have 7 franchise brands in 10 countries, approximately 600 franchisees and 2,500 mobile service vehicles. We focus on resilient reactive and planned services and carry out approximately 1.3m jobs per year at an average value of Β£325 for approximately 65,000 commercial customers. We earn an average management service fee of 15% from each job undertaken by our franchise partners.

Our market-leading brands include Pirtek, Metro Rod and Filta. We employ approximately 600 people across the Group and there are over 3,000 people employed in the franchise community.

For further information, visitΒ www.franchisebrands.co.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBBGDLCXBDGLG
Date   Source Headline
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
17th Mar 20257:00 amRNSNotice of Results
25th Feb 20253:47 pmRNSHolding(s) in Company
20th Feb 20252:30 pmRNSCapital Markets Day
13th Feb 20257:00 amRNSAppointment of CFO and Group Finance Director
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
7th Feb 20257:00 amRNS-RCapital Markets Day
31st Jan 20257:00 amRNSDirectors’ dealings
28th Jan 20257:00 amRNSTrading Update
16th Jan 20257:00 amRNSAppointment of Non-Executive Director
13th Nov 20242:00 pmRNSGrant of Options to director
12th Nov 20247:00 amRNSQ3 Trading Update
23rd Oct 20247:00 amRNSGroup CEO Appointment and Listing Consideration
15th Oct 20247:00 amRNSRe-commencement of Share purchase programme
23rd Sep 202411:54 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSDirector/PDMR shareholding & holding in Company
17th Sep 20247:00 amRNSInterim Results
9th Sep 20247:00 amRNSNotice of Interim Results
30th Jul 20248:33 amRNSDirector/PDMR Shareholding
18th Jul 20241:55 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement and Trading Update
8th Jul 20241:42 pmRNSGrant of Options
27th Jun 202410:01 amRNSAnnual General Meeting and proxy voting deadline
21st Jun 20244:40 pmRNSPublication of Annual Report and Accounts
20th Jun 20247:01 amRNSBoard and management changes
20th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSTrading Update, Final Dividend & AGM
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.